A
Angelo Maria Patti
Researcher at University of Palermo
Publications - 58
Citations - 1611
Angelo Maria Patti is an academic researcher from University of Palermo. The author has contributed to research in topics: Type 2 diabetes & Medicine. The author has an hindex of 19, co-authored 48 publications receiving 1095 citations.
Papers
More filters
Journal ArticleDOI
The Role of Nutraceuticals in Statin Intolerant Patients
Maciej Banach,Angelo Maria Patti,Rosaria Vincenza Giglio,Arrigo F G Cicero,Atanas G. Atanasov,Atanas G. Atanasov,Gani Bajraktari,Eric Bruckert,Olivier S. Descamps,Dragan M. Djuric,Marat V. Ezhov,Zlatko Fras,Stephan von Haehling,Niki Katsiki,Michel Langlois,Gustavs Latkovskis,G.B. John Mancini,Dimitri P. Mikhailidis,Olena Mitchenko,Patrick M. Moriarty,Paul Muntner,Dragana Nikolic,Demosthenes B. Panagiotakos,György Paragh,Bernhard Paulweber,Daniel Pella,Christos Pitsavos,Željko Reiner,Giuseppe M.C. Rosano,Robert S. Rosenson,Jacek Rysz,Amirhossein Sahebkar,Maria-Corina Serban,Dragos Vinereanu,Michal Vrablík,Gerald F. Watts,Nathan D. Wong,Manfredi Rizzo +37 more
TL;DR: The aim of this expert opinion paper is to provide the first attempt at recommendation on the management of statin intolerance through the use of nutraceuticals with particular attention on those with effective low-density lipoprotein cholesterol reduction.
Journal ArticleDOI
Management of Statin Intolerance in 2018: Still More Questions Than Answers.
Peter P. Toth,Angelo Maria Patti,Rosaria Vincenza Giglio,Dragana Nikolic,Giuseppa Castellino,Manfredi Rizzo,Maciej Banach +6 more
TL;DR: The definition of statin intolerance is focused on and the development of clinical and therapeutic strategies for its management, including emerging alternative therapies are focused on.
Journal ArticleDOI
Natural approaches in metabolic syndrome management
Angelo Maria Patti,Khalid Al-Rasadi,Rosaria Vincenza Giglio,Dragana Nikolic,Carlo Mannina,Giuseppa Castellino,Roberta Chianetta,Maciej Banach,Arrigo F G Cicero,Giuseppe Lippi,Giuseppe Montalto,Manfredi Rizzo,Peter P. Toth +12 more
TL;DR: The study of the beneficial effects of nutraceuticals in patients with MetS, including product standardization, duration of supplementation and definition of optimal dosing, could help better define appropriate treatment.
Journal ArticleDOI
Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study.
Peter P. Toth,Peter P. Toth,Angelo Maria Patti,Dragana Nikolic,Rosaria Vincenza Giglio,Giuseppa Castellino,Teresa Biancucci,Fabiana Geraci,Sabrina David,Giuseppe Montalto,Ali A. Rizvi,Manfredi Rizzo,Manfredi Rizzo +12 more
TL;DR: The aim of the present study was to fully investigate the effects of a Bergamot extract on cardio-metabolic parameters, including plasma lipids, atherogenic lipoproteins and subclinical atherosclerosis, in patients with moderate hypercholesterolemia.
Journal ArticleDOI
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study
Manfredi Rizzo,Manfredi Rizzo,Ali A. Rizvi,Angelo Maria Patti,Dragana Nikolic,Rosaria Vincenza Giglio,Giuseppa Castellino,Giovanni Li Volti,Massimiliano Caprio,Giuseppe Montalto,Giuseppe Montalto,Vincenzo Provenzano,Stefano Genovese,Antonio Ceriello +13 more
TL;DR: Liraglutide improves cardio-metabolic risk factors in subjects with the MetS in a real-world study and shows a significant reduction in waist circumference, body mass index, fasting glycemia, HbA1c, total- and LDL-cholesterol, triglycerides, and cIMT during the 18-month follow-up.